WOMEN’S HEALTH · PATIENT AND CLINICIAN UPDATE

Women’s Health
Clinical Update

23 October 2026

This week’s evidence supports practical improvements rather than new medicines: respectful, individualised weight counselling in pregnancy; deliberate follow-up of cervical screening for women facing access barriers; and keeping both remote and in-person pathways available for timely reproductive healthcare.

22 OCTOBER · PEER-REVIEWED COHORT STUDY

Pregnancy weight gain and serious maternal complications

Clinical question and result. Is weight gain during pregnancy associated with severe maternal illness across different pre-pregnancy BMI groups? In more than 1.03 million singleton pregnancies in Ontario, excessive gain was associated with a higher rate of severe maternal morbidity in every BMI category. Inadequate gain was also associated with higher risk among women in the normal-weight and overweight groups. The absolute differences were modest: severe morbidity occurred in 12.18 per 1,000 births with guideline-range gain, 14.08 with inadequate gain and 16.09 with excessive gain.

Evidence strength and limitations. The study was very large and used linked birth and hospital records, but it was retrospective and cannot prove that weight gain caused the complications. Fluid retention from pre-eclampsia may partly explain higher late-pregnancy weight, and the composite outcome combined conditions with different causes. Canadian findings may not transfer directly to South African populations or resources.

Practical implication. Record pre-pregnancy weight or early BMI where possible and discuss a realistic weight-gain range without stigma. Review nutrition, blood pressure, diabetes risk and other medical conditions together. Do not turn the study’s estimated lowest-risk values into new targets or encourage weight loss during pregnancy without specialist guidance.

Verdict: Practice remains unchanged—continue local pregnancy guidance, but make weight monitoring and individualised counselling more consistent.

Read the JAMA Network Open study →

20 OCTOBER · PEER-REVIEWED COHORT STUDY

Cervical screening gaps are greatest where access is hardest

Clinical question and result. Which forms of social vulnerability are linked to missed cervical screening? Among 18,253 pregnant women at one French maternity unit, only 56.1% were up to date when first seen. Every identified vulnerability profile was associated with more missed screening. Migration or language barriers showed the largest difference, while women exposed to violence had both lower screening participation and more detected cervical lesions.

Evidence strength and limitations. This was a large, diverse clinical cohort, including many women of North and sub-Saharan African background. However, it came from one French hospital, was observational and used a three-year screening definition during a transition from cytology to HPV testing. The associations may reflect several unmeasured barriers and do not show that a particular intervention will improve outcomes.

Practical implication. Antenatal and postnatal visits are opportunities to check whether cervical screening is overdue and arrange follow-up under the local programme. Use professional language support, private enquiry about safety, and trauma-informed care. Screening and violence enquiries must remain voluntary, confidential and sensitive.

Verdict: Change care processes now—add screening-status checks and barrier-sensitive follow-up, while keeping national screening intervals unchanged.

Read the JAMA Network Open study →

22 OCTOBER · PEER-REVIEWED CROSS-SECTIONAL STUDY

Remote and in-person abortion care reach different patients

Clinical question and result. Do people using telehealth medication abortion differ from those attending a clinic? In a US study of 13,548 adults, telehealth users were more often under six weeks’ gestation, lived farther from a clinic and had no children. This suggests remote and in-person services are complementary rather than interchangeable.

Evidence strength and limitations. The study included a large clinical sample, but compared only one telehealth service with one clinic in two US states. It did not randomise care, measure safety or completion outcomes, include procedural abortion, or study South African law and health systems. Patient preference and access barriers could not be separated.

Practical implication. Where permitted and clinically appropriate, confidential remote information, triage and follow-up may reduce travel and delay. In-person assessment must remain available for people who prefer it, need examination or ultrasound, have later or uncertain gestation, or have symptoms requiring urgent assessment. Unverified online or street medicines are not the same as clinician-supported telehealth care.

Verdict: Watch and improve access design; do not change clinical protocols or eligibility rules on this study alone.

Read the JAMA Network Open study →

MOST WORTH READING · RANKED

Three papers for practice

Evidence window: material published or meaningfully updated from 17 to 23 October 2026. All three selections are peer-reviewed; no preprints or conference-only claims are included. No comparably important new NICE, Irish HSE or South African national women’s-health guideline was verified during this period. Educational summary only; it does not replace individual assessment or local clinical guidance.

Earlier women’s-health update: 16 October. Previous editions remain available through their original links.